Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation - a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The trabeculectomy is the gold standard in glaucoma surgery, nevertheless often postoperative interventions have to be done. (1),(2) The PreserFlo MicroShunt (Santen, Osaka, Japan) implantation occurs without critical steps of trabeculectomy. (3) According to a study a 20% eye pressure reduction was achieved in 53.9% of patients one year after PreserFlo MicroShunt implantation and the risk of postoperative hypotony was clearly minimized. (4) It has been shown that after trabeculectomy there is a stable development of visual fields in the first 3 months after surgery and then, despite adequate intraocular pressure reduction, visual fields deteriorate. (5) At the Klinikum Klagenfurt structural and functional changes after PreserFlo MicroShunt Implantation shall be evaluated.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Patients with insufficient eye pressure control despite IOP (intraocular pressure)-lowering therapy

• Diagnosis of POAG (primary open angle glaucoma)

• Diagnosis of PEG (pseudoexfoliation glaucoma)

• Diagnosis of PDG (pigment dispersion glaucoma)

• Diagnosis of NTG (normal tension glaucoma)

• Agreement of patients to participate in the study

Locations
Other Locations
Austria
KlinikumKlagenfurt
RECRUITING
Klagenfurt
Contact Information
Primary
Carmen Gruzei
carmen.gruzei@kabeg.at
+4346353826332
Time Frame
Start Date: 2021-10-12
Estimated Completion Date: 2024-09-09
Participants
Target number of participants: 100
Sponsors
Collaborators: Medical University of Graz
Leads: Klinikum Klagenfurt am Wörthersee

This content was sourced from clinicaltrials.gov